Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · JBT Marel (JBTM)

JBT Marel Q1 2026 revenue rises 10% to $936 million; full-year guidance reiterated

Positive Impact 3 of 5 earnings Written later

JBT Marel reported first quarter 2026 results on May 4, 2026, with revenue up 10% to $936 million and net income of $45 million, compared with a net loss of $173 million a year earlier. The company reiterated its full-year 2026 guidance, including revenue of $3,990 million to $4,065 million and adjusted EPS of $8.00 to $8.50.

Key points

  • Diluted EPS was $0.86 versus a loss of $3.35 a year earlier; adjusted EPS was $1.58 versus $0.97.
  • Orders totaled $1.07 billion and quarter-ending backlog was $1.49 billion.
  • Operating cash flow was $119 million and free cash flow was $100 million; net debt to trailing twelve months adjusted EBITDA was 2.6x.
  • Protein Solutions segment adjusted EBITDA margin was 21.7%, while Prepared Food and Beverage Solutions margin fell to 14.7%, down 170 basis points.

The filing

CompanyJBT Marel (JBTM)
Form8-K, current report
Filed with the SECMay 4, 2026, 4:55 PM ET
Accession number0001628280-26-029903

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 12:59 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 04, 2026.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.